1Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med, 1998, 339..321-328.
2Maeda K, Tsutamoto T, Wada A, et al. Plasma Dram natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J, 1998, 135:825-832.
3Hobbs RE. Using BNP to diagnose, manage, and treat heart failure. Cleve Clin J Med, 2003, 70:333-336.
4Tsutamoto T, Wada A, Maeda K, et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation, 1997, 96: 509-516.
5Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med, 2002, 347:161-167.
6Clerico A, Iervasi G, Del Chicca MG, et al. Circulating levels of cardiac natriuretic peptides(ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart failure. J Endocrinol Invest, 1998, 21: 170-179.
7Lee SC, Stevens TL, Sandberg SM, et al. The potential of brain natriuretic peptide as a biomarker for New York Heart Association class during the outpatient treatment of heart failure. J Card Fail, 2002, 8:149-154.
